Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium

Oncotarget
Laura H RodgersJoanna E Burdette

Abstract

High-grade serous carcinoma (HGSC) is the most common and lethal form of ovarian cancer. PAX8 is a transcription factor expressed in fallopian tube epithelial cells and in 80-96% of HGSC tumors. The ovarian surface epithelium (OSE) only acquires PAX8 expression after malignant transformation. In this study, forced PAX8 expression in OSE cells increased proliferation and migration through upregulation of EMT factors such as N-cadherin and Fibronectin. OSE cells expressing PAX8 also had an increase in the FOXM1 pathway, but PAX8 alone was not sufficient to drive tumorigenesis. PAX8 knockdown in the oviductal epithelium cells did not decrease expression of the FOXM1 pathway and induced only a slight decrease in cell proliferation. No changes in migration, cell cycle, or apoptosis were detected after PAX8 knockdown in oviductal cells. Finally, PAX8 knockdown in HGSC cell lines resulted in increased apoptosis and decreased FOXM1 levels. The results presented here suggest that PAX8 has a cell specific role in governing proliferation and migration in nontransformed ovarian surface epithelium cells compared to the oviductal cells, but its reduction in serous cancer cell lines provides a common mechanism for reducing cell survival.

References

Jan 10, 1998·The Journal of Biological Chemistry·G C FraizerG F Saunders
May 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·N AuerspergC D Roskelley
Nov 25, 2003·Nature Reviews. Genetics·Akio Kobayashi, Richard R Behringer
Oct 27, 2006·Gynecologic Oncology·Nathan J BowenJohn F McDonald
Apr 5, 2007·Nature Protocols·Vanicha Vichai, Kanyawim Kirtikara
Dec 7, 2007·Disease Markers·Donna Badgwell, Robert C Bast
Aug 30, 2008·The American Journal of Surgical Pathology·Daisuke NonakaRobert A Soslow
Apr 29, 2009·Cell Proliferation·Kate LawrensonD Dafou
Aug 22, 2009·The EMBO Journal·Hyun Jung ParkPradip Raychaudhuri
Oct 7, 2009·Cell Cycle·Bulbul PanditAndrei L Gartel
Apr 24, 2010·The American Journal of Surgical Pathology·Anna R LauryMichelle S Hirsch
Jul 8, 2010·Diagnostic Cytopathology·Guo-Xia TongEllen Greenebaum
Feb 15, 2011·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Ayhan OzcanLuan D Truong
May 10, 2011·The American Journal of Surgical Pathology·Anna R LauryMichelle S Hirsch
Jun 30, 2011·Cancer Research·Pradip Raychaudhuri, Hyun Jung Park
Jul 2, 2011·Nature·Cancer Genome Atlas Research Network
Jul 13, 2011·Proceedings of the National Academy of Sciences of the United States of America·Hiu Wing CheungWilliam C Hahn
Apr 26, 2012·BMC Genomics·Sergio Ruiz-LlorentePilar Santisteban
Jul 11, 2013·Nature Communications·Silvia DomckeNikolaus Schultz
Jul 23, 2013·Cell Death & Disease·Tina Di PalmaMariastella Zannini
Dec 7, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R J Kurman
Apr 29, 2014·BMC Cancer·Tina Di PalmaMariastella Zannini
Jul 30, 2014·Nature Reviews. Endocrinology·Priyadarshini Raman, Ronald J Koenig
Mar 27, 2015·International Journal of Cancer. Journal International Du Cancer·Suzanne M QuartuccioJoanna E Burdette
May 15, 2015·Oncotarget·Sharon L EddieJoanna E Burdette
Jun 9, 2015·Gynecologic Oncology·Anirban K MitraJoanna E Burdette
Jun 17, 2015·Human Pathology·Emily K AdlerKate Lawrenson
Sep 1, 2015·Gynecologic Oncology·Kevin M EliasRonny Drapkin
Jan 9, 2016·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal

Citations

Jun 1, 2017·American Society of Clinical Oncology Educational Book·Elise C Kohn, S Percy Ivy
Jan 10, 2018·Oncotarget·Emily K AdlerSimon A Gayther
Dec 14, 2019·Cancer Cell International·Amata Amy SorianoMariastella Zannini
Feb 13, 2021·International Journal of Molecular Sciences·Stanislaw SupplittIzabela Laczmanska
Dec 29, 2020·Cancer Research·Daniele Chaves-MoreiraRonny Drapkin
Feb 10, 2021·The Journal of Clinical Investigation·Helen E BurstonRobert Rottapel
Jan 26, 2021·Genes & Cancer·Pacharla ManasaTrivadi S Ganesan

Methods Mentioned

BETA
dissection
transfection
Flow cytometry
transfections
protein assay

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

© 2021 Meta ULC. All rights reserved